Guy C. Toner
The University of Melbourne · 163 works · 5,182 citations · h-index 36
Top works
- Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups.
- Activity of Gemcitabine in Patients with Advanced Ovarian Cancer: Responses Seen Following Platinum and Paclitaxel
- Initial Paclitaxel Improves Outcome Compared With CMFP Combination Chemotherapy as Front-Line Therapy in Untreated Metastatic Breast Cancer
- Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selection.
- Filgrastim in Patients with Chemotherapy-Induced Febrile Neutropenia: A Double-Blind, Placebo-Controlled Trial
- Serum tumor marker half-life during chemotherapy allows early prediction of complete response and survival in nonseminomatous germ cell tumors.
- Hair Depigmentation Is a Biological Readout for Pharmacological Inhibition of KIT in Mice and Humans
- A randomised phase III study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable non-small cell lung cancer: final report of an Australian multi-centre trial
- ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up
- Treatment with the novel anti-angiogenic agent PI-88 is associated with immune-mediated thrombocytopenia
- ACCURACY OF COMPUTED TOMOGRAPHY GUIDED CORE NEEDLE BIOPSY OF MUSCULOSKELETAL TUMOURS
- R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor 1 Receptor, in Patients With Recurrent or Refractory Ewing Sarcoma Family of Tumors: Results of a Phase II Sarcoma Alliance for Research Through Collaboration Study
- Phase II study of docetaxel and cisplatin in advanced non-small-cell lung cancer.
- A phase I trial of recombinant human interleukin-1 beta alone and in combination with myelosuppressive doses of 5-fluorouracil in patients with gastrointestinal cancer
- Extragonadal and poor risk nonseminomatous germ cell tumors. Survival and prognostic features
- Active Surveillance Is the Preferred Approach to Clinical Stage I Testicular Cancer
- Phase II trial of a 3-hour infusion of paclitaxel in previously untreated patients with advanced non-small-cell lung cancer.
- Phase I trial of docetaxel and cisplatin in previously untreated patients with advanced non-small-cell lung cancer.
- Cremophor Pharmacokinetics in Patients Receiving 3-, 6-, and 24-Hour Infusions of Paclitaxel
- Gene expression profiling of human colon xenograft tumors following treatment with SU11248, a multitargeted tyrosine kinase inhibitor